P-selectin imaging in cardiovascular disease: What you see is what you get?

Journal of Nuclear Medicine

Volumn 52, Issue 9, 2011, Pages 1337-1338

  Boersma, Hendrikus H ^a   De Haas, Hans J ^a   Reutelingsperger, Chris P M ^b   Slart, Riemer H J A ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FUCOIDAN TC 99M; PADGEM PROTEIN; TRACER; UNCLASSIFIED DRUG;

ACUTE CORONARY SYNDROME; CARDIOVASCULAR DISEASE; CORONARY ARTERY ATHEROSCLEROSIS; GOOD MANUFACTURING PRACTICE; HEART MUSCLE ISCHEMIA; HEMOSTASIS; HUMAN; INFLAMMATION; INTERMETHOD COMPARISON; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOCARDIOGRAPHY; REPERFUSION INJURY; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THROMBOCYTE; THROMBUS;

ANIMALS; BLOOD PLATELETS; ENDOTHELIUM, VASCULAR; MALE; P-SELECTIN; POLYSACCHARIDES; RADIOPHARMACEUTICALS; THROMBOSIS;

EID: 80052607905     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.111.090506     Document Type: Review

References (16)

1. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation. 2002;105:1135-1143. (Pubitemid 34212626)
2. Borissoff JI, Spronk HM, ten Cate H. The hemostatic system as a modulator of atherosclerosis. N Engl J Med. 2011;364:1746-1760.
3. Emsley HC, Smith CJ, Tyrrell PJ, Hopkins SJ. Inflammation in acute ischemic stroke and its relevance to stroke critical care. Neurocrit Care. 2008;9:125-138.
4. Yellon DM, Hausenloy DJ. Myocardial reperfusion injury. N Engl J Med. 2007;357:1121-1135.
5. Mann J, Davies MJ. Mechanisms of progression in native coronary artery disease: role of healed plaque disruption. Heart. 1999;82:265-268. (Pubitemid 29429594)
6. Blann AD, Nadar SK, Lip GY. The adhesion molecule P-selectin and cardiovascular disease. Eur Heart J. 2003;24:2166-2179. (Pubitemid 37522669)
7. Jacobin-Valat MJ, Deramchia K, Mornet S, et al. MRI of inducible P-selectin expression in human activated platelets involved in the early stages of atherosclerosis. NMR Biomed. December 29, 2010 [Epub ahead of print].
8. McAteer MA, Schneider JE, Ali ZA, et al. Magnetic resonance imaging of endothelial adhesion molecules in mouse atherosclerosis using dual-targeted microparticles of iron oxide. Arterioscler Thromb Vasc Biol. 2008;28:77-83.
9. Barber PA, Foniok T, Kirk D, et al. MR molecular imaging of early endothelial activation in focal ischemia. Ann Neurol. 2004;56:116-120. (Pubitemid 38857366)
10. Kaufmann BA, Lewis C, Xie A, Mirza-Mohd A, Lindner JR. Detection of recent myocardial ischaemia by molecular imaging of P-selectin with targeted contrast echocardiography. Eur Heart J. 2007;28:2011-2017. (Pubitemid 47591499)
11. Villanueva FS, Lu E, Bowry S, et al. Myocardial ischemic memory imaging with molecular echocardiography. Circulation. 2007;115:345-352. (Pubitemid 46151660)
12. Rouzet F, Bachelet-Violette L, Alsac J, et al. Radiolabeled fucoidan as a P-selectin targeting agent for in vivo imaging of platelet-rich thrombus and endothelial activation. J Nucl Med. 2011;52:1433-1440.
13. Hermus L, Van Dam GM, Zeebregts CJ. Advanced carotid plaque imaging. Eur J Vasc Endovasc Surg. 2010;39:125-133.
14. Kolodgie FD, Petrov A, Virmani R, et al. Targeting of apoptotic macrophages and experimental atheroma with radiolabeled annexin V: a technique with potential for noninvasive imaging of vulnerable plaque. Circulation. 2003;108:3134-3139. (Pubitemid 38031804)
15. 18F-FDG accumulation in atherosclerotic plaques: immunohistochemical and PET imaging study. J Nucl Med. 2004;45:1245-1250.
16. Downey JM, Cohen MV. Why do we still not have cardioprotective drugs? Circ J. 2009;73:1171-1177.